Biocon

Biocon case: Sebi bans 6 entities for 2 years for manipulative trades

Biocon case: Sebi bans 6 entities for 2 years for manipulative trades

Sebi on Wednesday barred six entities from the capital markets for two years for indulging in manipulative trading in the shares of Bioco...Read More

Results: Biocon’s revenue up at Rs 2,044 crore in Q4 of FY21

Results: Biocon’s revenue up at Rs 2,044 crore in Q4 of FY21

Bangalore-based Biocon reported a 26 per cent rise in consolidated revenue from Rs 1,621 crore in Q4FY20 to Rs 2,044 crore in Q4FY 2021. ...Read More

Biocon's Kiran Mazumdar first Indian to be appointed on board of Sloan Kettering Cancer Centre

Biocon's Kiran Mazumdar first Indian to be appointed on board of Sloan Kettering Cancer Centre

Kiran Mazumdar Shaw, Executive Chairperson, Biocon Ltd has been appointed to the board of trustees of US-based Memorial Sloan Kettering C...Read More

Biocon enters Latin American market with its generic drugs

Biocon enters Latin American market with its generic drugs

Global biopharmaceutical company Biocon has launched its generic drugs in the Brazil market. The company is making an entry into Latin A...Read More

Companies 'feel betrayed' due to capping of COVID-19 vaccine price: Shaw

Companies 'feel betrayed' due to capping of COVID-19 vaccine price: Shaw

Mazumdar-Shaw asked, "If WHO has agreed to USD 3 per dose, why beat them down to USD 2?"

Biocon Q3 net profit falls 19 pc to Rs 186.6 cr

Biocon Q3 net profit falls 19 pc to Rs 186.6 cr

The company's revenue from operations rose to Rs 1,851 crore for the quarter under consideration, up 7.81 per cent, as against Rs 1,716.8...Read More

HCL's Roshni Nadar richest woman in India; a third of entrants in list self-made

HCL's Roshni Nadar richest woman in India; a third of entrants in list self-made

A total of 31 women in the list of 100 having a networth of at least Rs 100 crore, prepared by Hurun India and Kotak Wealth, are "self-ma...Read More

Biocon to acquire 26% stake in Hinduja Renewables Two

Biocon to acquire 26% stake in Hinduja Renewables Two

The indicative time period for completion of the acquisition is December 15, 2020, Biocon said in a BSE filing.

COVID-19 vaccine may be available in India by June 2021, says Kiran Mazumdar Shaw

COVID-19 vaccine may be available in India by June 2021, says Kiran Mazumdar Shaw

Chairperson and managing director of Bengaluru-based Biocon Kiran Mazumdar Shaw said a vaccine for COVID-19 could be available in India b...Read More

Biocon chief Kiran Mazumdar-Shaw tests positive for COVID-19

Biocon chief Kiran Mazumdar-Shaw tests positive for COVID-19

Bengaluru: Biocon chairperson Kiran Mazumdar-Shaw on Monday night said she tested COVID-19 positive."I have added to the COVID count by t...Read More

Biocon shares decline nearly 4 pc after Q1 earnings

Biocon shares decline nearly 4 pc after Q1 earnings

New Delhi: Shares of biotechnology major Biocon on Friday dropped nearly 4 per cent after the company reported a 26.30 per cent decline i...Read More

DCGI permits use of Biocon Biologics’ CytoSorb to treat COVID-19 patients

DCGI permits use of Biocon Biologics’ CytoSorb to treat COVID-19 patients

Biocon’s subsidiary Biocon Biologics has received Drugs Controller General of India’s (DCGI) approval to use CytoSorb to treat critical C...Read More

Biocon Q4 net profit falls 42 pc to Rs 123 cr due to one-time COVID-19 impact

Biocon Q4 net profit falls 42 pc to Rs 123 cr due to one-time COVID-19 impact

The company had posted a net profit of Rs 214 crore for the corresponding period of the previous fiscal, Biocon said in a statement.

Biocon, Mylan launch Fulphila, biosimilar Pegfilgrastim in Australia

Biocon, Mylan launch Fulphila, biosimilar Pegfilgrastim in Australia

Biocon Ltd. and Mylan N V on Tuesday announced the launch of Fulphila, a biosimilar to Neulasta (pegfilgrastim), in Australia.

Biotechnology major Biocon Q3 net dips 7% to Rs 203 crore

Biotechnology major Biocon Q3 net dips 7% to Rs 203 crore

The company had posted a net profit of Rs 217.2 crore for the corresponding period of the previous fiscal, Biocon said.

True North to get 2.4% Biocon arm stake

True North to get 2.4% Biocon arm stake

New Delhi: Pharmaceuticals major Biocon Ltd on Monday said that its subsidiary Biocon Biologics India has approved the acquisition of 2.4...Read More

Kiran Mazumdar Shaw settles 'insider trading case' with Sebi in Infosys matter

Kiran Mazumdar Shaw settles 'insider trading case' with Sebi in Infosys matter

Mazumdar Shaw, who is also a chairman of Biocon, was alleged to have violated provisions of the Prohibition of Insider Trading (PIT) regu...Read More

Biocon net at Rs 216 cr for the quarter ended September

Biocon net at Rs 216 cr for the quarter ended September

New Delhi: Biotechnology major Biocon reported a net profit of Rs 215.7 crore for the quarter ended September 30, 2019.The company had p...Read More

It’s a truce says, Biocon chief Kiran Mazumdar Shaw

It’s a truce says, Biocon chief Kiran Mazumdar Shaw

On Thursday Finance Minister Nirmala Sitharaman had defended her decision to ban e-cigarettes after Biocon chief Kiran Mazumdar-Shaw ques...Read More

“I've been working on the economy, tweets FM after criticism

“I've been working on the economy, tweets FM after criticism

Reminds Biocon chief of govt's fiscal steps on growth revival

Free Press Journal

www.freepressjournal.in